News
GNTA
1.840
+1.66%
0.030
Weekly Report: what happened at GNTA last week (0622-0626)?
Weekly Report · 8h ago
Genenta Science Faces Court-Ordered Suspension of Corporate Purpose Amendment While Voting Rights Reform Stands
TipRanks · 2d ago
Genenta Science Sets CEO Severance Terms and Narrows Non-Compete in June 2026
TipRanks · 5d ago
Weekly Report: what happened at GNTA last week (0615-0619)?
Weekly Report · 06/22 10:39
Genenta Calls June 29 Shareholder Vote on Name Change, Capital Moves and Reverse Split
TipRanks · 06/17 13:30
Weekly Report: what happened at GNTA last week (0608-0612)?
Weekly Report · 06/15 10:39
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Benzinga · 06/11 12:05
12 Health Care Stocks Moving In Tuesday's After-Market Session
Benzinga · 06/09 21:06
Weekly Report: what happened at GNTA last week (0601-0605)?
Weekly Report · 06/08 10:34
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Benzinga · 06/04 12:05
12 Health Care Stocks Moving In Tuesday's After-Market Session
Benzinga · 06/02 21:09
12 Health Care Stocks Moving In Tuesday's Intraday Session
Benzinga · 06/02 17:06
12 Health Care Stocks Moving In Monday's Intraday Session
Benzinga · 06/01 17:06
12 Health Care Stocks Moving In Monday's Pre-Market Session
Benzinga · 06/01 12:06
Weekly Report: what happened at GNTA last week (0525-0529)?
Weekly Report · 06/01 10:40
Why Taylor Morrison Home Shares Are Trading Higher By Over 20%; Here Are 20 Stocks Moving Premarket
Benzinga · 06/01 10:01
Genenta Science Closes All-Share Acquisition of Remaining Stake in A.T.C.
TipRanks · 05/29 20:29
Weekly Report: what happened at GNTA last week (0518-0522)?
Weekly Report · 05/25 10:44
Genenta Science Ends Ospedale San Raffaele License to Refocus Strategy
TipRanks · 05/19 22:54
Weekly Report: what happened at GNTA last week (0511-0515)?
Weekly Report · 05/18 10:43
More
Webull provides a variety of real-time GNTA stock news. You can receive the latest news about Genenta Science Spa through multiple platforms. This information may help you make smarter investment decisions.
About GNTA
Genenta Science SpA is an Italy-based company engaged in clinical-stage biotechnology research. The Company focuses on the development of lentivirus-based gene and cell therapies in cancer. It uses gene-based cytokine delivery to activate the immune system within the tumor providing the anti-tumor response. The Company not only operates locally but also is present in global markets, including the United States.